Cross-colonization of infants with probiotic organisms in a neonatal unit

L Hickey1, S M Garland2, S E Jacobs3

  • 1Department of Neonatal Medicine, Royal Children's Hospital, Parkville, Victoria, Australia; School of Medicine & Medical Science, University College Dublin, Ireland; Neonatal Services, Royal Women's Hospital, Parkville, Victoria, Australia.

Insights

Probiotic cross-colonization between infants in a neonatal unit was assessed. The study found a low rate of probiotic transfer between infants, even when probiotics were administered to preterm infants during a clinical trial.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Clinical Trials

Background:

  • Neonatal units are susceptible to microbial transmission.
  • Probiotics are increasingly used in preterm infants for potential health benefits.
  • Understanding probiotic cross-colonization is crucial for infection control and efficacy.

Purpose of the Study:

  • To evaluate the extent of probiotic cross-colonization among infants in a neonatal intensive care unit.
  • To determine if probiotic administration to preterm infants leads to transmission to non-recipients.
  • To compare cross-colonization rates with previous studies.

Main Methods:

  • Stool samples were collected from all infants in the neonatal unit at two time points: during and after a clinical trial involving probiotic administration.
  • Infant samples were analyzed for the presence of probiotics.
  • Colonization rates were calculated for infants receiving probiotics and those not receiving them.

Main Results:

  • During the clinical trial, 5 out of 5 infants receiving probiotics and 3 out of 38 infants not receiving probiotics showed probiotic colonization.
  • After the trial completion, only 1 out of 44 infants tested was found to be colonized.
  • The observed rate of probiotic cross-colonization was lower than previously reported in similar studies.

Conclusions:

  • Probiotic cross-colonization between infants in this neonatal unit was limited.
  • The findings suggest that probiotic transfer may not be a significant issue in this setting.
  • Further research is needed to fully understand the dynamics of probiotic colonization in neonatal populations.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
53
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
244
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
128
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
83
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
64